Using drugs that inhibit enzymes called CDK4/6 and CDK2 extends the G1 phase of the cell cycle and helps to slow the growth of drug-resistant breast cancer.
Researchers at The University of Texas MD Anderson Cancer Center have found that a mitochondrial enzyme, GFER, creates an ...
A hidden layer may unlock long-lasting solid-state batteries, boosting cycle life and stability after thousands of charges.
Some fungi live up to 2,500 years thanks to an internal system that eliminates harmful cells and prevents genetic mutations.
Humans have it. So does Drosophila. But not yeast. That "it" is a small pause at the start of gene activity—a brief molecular halt that may have helped life evolve from simple cells to complex animals ...
Disrupted sleep and shift work may fuel aggressive breast cancer by weakening immunity and altering tissue. New research ...
Morning Overview on MSN
Cancer treatment timing may matter more than you think, study says
Cancer care has long focused on what drugs to give and in what doses, but a growing body of evidence suggests the clock on the wall may be just as important. Researchers are finding that the hour a ...
Platinum-resistant recurrent epithelial ovarian cancer carries a bleak prognosis, with single-agent chemotherapy yielding response rates below 20% ...
Live Science on MSN
Gray hair may have evolved as a protection against cancer, study hints
Graying hair could be a sign that the body is effectively protecting itself from cancer, a new study suggests. Cancer-causing triggers, such as ultraviolet (UV) light or certain chemicals, activate a ...
-- ImCheck Reports Durable Responses and Early Overall Survival Signal with ICT01 in First-line AML at ASH 2025 -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results